DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

Not Applicable

Completed

Conditions: Multiple Sclerosis

Interventions: Drug: Tysabri

First Posted Date: 2010-02-19

Last Posted Date: 2017-10-25

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01071512

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

ACT-HF: Attention, Cognition and Self-Management in Heart Failure

Completed

Conditions: Heart Failure

First Posted Date: 2010-02-08

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 72

Registration Number: NCT01064765

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC

Phase 1

Terminated

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: RAD001 (in addition to standard radiation and chemotherapy)

First Posted Date: 2010-02-05

Last Posted Date: 2014-01-17

Lead Sponsor: University of Chicago

Target Recruit Count: 3

Registration Number: NCT01063478

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

N-Acetyl Cysteine in Pathologic Skin Picking

Phase 2

Completed

Conditions: Pathologic Skin Picking
Neurotic Excoriation
Psychogenic Excoriation
Dermatillomania

Interventions: Drug: N-Acetyl Cysteine
Drug: Placebo

First Posted Date: 2010-02-05

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 66

Registration Number: NCT01063348

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC

Not Applicable

Completed

Conditions: Advanced Non-squamous Non-Small Cell Lung Cancer

Interventions: Drug: Pemetrexed
Drug: Carboplatin
Drug: Bevacizumab 7.5 mg/kg
Drug: Bevacizumab 15 mg/kg

First Posted Date: 2010-02-05

Last Posted Date: 2019-11-18

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01063283

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States
🇺🇸
Ingalls Memorial Hospital, Harvey, Illinois, United States
🇺🇸
North Shore University Health System, Evanston, Illinois, United States

Continuous Venovenous Hemofiltration Versus Continuous Venovenuous Hemodialysis

Not Applicable

Completed

Conditions: Acute Renal Failure

Interventions: Procedure: Continuous Venovenous Hemodialysis (CVVHD)
Procedure: Continuous Venovenous Hemofiltration (CVVH)

First Posted Date: 2010-02-04

Last Posted Date: 2023-05-10

Lead Sponsor: University of Chicago

Target Recruit Count: 11

Registration Number: NCT01062984

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ

Phase 2

Terminated

Conditions: Ductal Carcinoma in Situ

Interventions: Drug: Polyphenon E

First Posted Date: 2010-02-02

Last Posted Date: 2020-04-09

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT01060345

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Development and Validation of a Tool to Measure Hand-off Quality

Completed

Conditions: Communication
Patient Care
Quality of Health Care

Interventions: Other: mock handoff exposure
Other: Introduction of CEX tool in Actual Hand-offs

First Posted Date: 2010-02-01

Last Posted Date: 2013-09-05

Lead Sponsor: University of Chicago

Target Recruit Count: 27

Registration Number: NCT01059942

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)

Phase 4

Terminated

Conditions: Critical Illness
Mechanical Ventilation

Interventions: Drug: Dexmedetomidine
Drug: Propofol
Drug: Fentanyl
Drug: Midazolam
Behavioral: Physical and Occupational Therapy

First Posted Date: 2010-02-01

Last Posted Date: 2018-07-03

Lead Sponsor: University of Chicago

Target Recruit Count: 41

Registration Number: NCT01059929

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

Understanding Sleep in Hospitalized Older Patients

Completed

Conditions: Sleep Deprivation
Sleep Fragmentation

First Posted Date: 2010-01-27

Last Posted Date: 2021-05-17

Lead Sponsor: University of Chicago

Target Recruit Count: 771

Registration Number: NCT01057823

Locations: 🇺🇸
The University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy